Skip to content

Author

Tao-Sheng Huang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Resistance mechanisms and countermeasures in CLDN18.2-positive tumors: from molecular networks to clinical practice

A central argument about treatment sequencing is advanced: because CLDN18.2 expression declines progressively under therapeutic pressure, continuous target-plus-chemotherapy acts on an eroding antigen substrate, for patients with high, homogeneous baseline expression, an early intensive induction followed by CLDN18.2-d...

Yu-Tao Xia, Ming-Fang Wang, Tao-Sheng Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.